Twitxy Saved

Adrian “WE NEED RCTS!” Hernandez

@texhern

Father of 4 boys, cardiologist, clinical researcher- outcomes, clinical trials, health policy & innovative methods; Director DCRI; Vice Dean, Duke School of Med
Duke University dcri.org/personnel/adri… Joined March 2011
1.3K Following 3.8K Followers 3.8K Posts

Latest posts 5

Adrian “WE NEED RCTS!” Hernandez @texhern
Fun baseball.. this weekend almost hit for the cycle - single, double and triple then game ended before his 4th AB
Prospect Select Scout Verified account @PSBaseballScout Sep 20
Collin Hernandez ('29, SC)⬇️

Relaxed semi-open stance w/ small LL, Keeps BP level, Hands Fire through the zone, Sends this one to the RCF gap for a 2B.

#CLTFall | @sox_carolina

👤 play.ps-baseball.com/player-profile…
View quoted post on X
Adrian “WE NEED RCTS!” Hernandez @texhern
So humbling and so true!

And why it’s important to have the definitive trials.

While #ai can do many things #hi (human intelligence) means testing our best hypotheses…especially when we’re aiming to improve health outcomes.
🧪➡️💊 Going from discovery ➡️ improved CV outcomes in RCTs is very very challenging

20+ once-promising CV targets, oral GP IIb/IIIa, CB1, PDE-3, niacin, Lp-PLA2, aliskiren, all failed or harmed in major CV outcome trials ❌📉

A validated mechanism ≠ a proven therapy ❤️🔬
View quoted post on X
Adrian “WE NEED RCTS!” Hernandez @texhern
Important point…. Different molecules can act differently

Will be interesting to see how all of the data unfolds
John Maraganore 🇺🇸🇬🇷🇺🇦 Verified account @JMaraganore Sep 4
WOW!

Hopefully this quote bodes well for other efforts: “The findings provide important new evidence on the relationship between Lp(a) lowering and cardiovascular outcomes.”

And remember, ASOs are NOT RNAi! novartis.com/news/media-rel…
View quoted post on X
Adrian “WE NEED RCTS!” Hernandez @texhern
Wow!

Mother Nature is always tricky!

#clinical trial randomization > Mendelian randomization
C. Michael Gibson MD Verified account @CMichaelGibson Sep 4
Breaking and MASSIVE:
Lowering Lp(a) with #pelacarsen in patients with elevated Lp(a) and heart disease does NOT improve cardiovascular outcomes in Phase 3 trial globenewswire.com/news-release/2…
View quoted post on X